MYLAN $31.55

up +0.32


22/5/2013 04:22 PM  |  NASDAQ : MYL  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 49% - MYL has outperformed the S&P 500 by 23%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. UPDATE: Morgan Stanley Downgrades Mylan to Equal-Weight Following ...

    Benzinga

  2. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ...

    Benzinga

  3. Mylan Announces Famy Care Received Final FDA Approval for ANDA for ...

    Benzinga

  4. Weekly Top Insider Sells: FIS, MYL, LMCA

    GuruFocus

  5. Mylan Inc (MYL) CEO Heather M Bresch sells 151,509 Shares

    GuruFocus

  6. A Merrier Christmas to These Insiders, Made the Most Money in Past ...

    GuruFocus

  7. Mylan Announces Settlement Related to Comtan

    Benzinga

  8. Mylan Launches Generic Version of Qualaquin Caps

    Benzinga

  9. Mylan Inc (MYL) Executive Chairman Robert J Coury sells 1,916,209 ...

    GuruFocus

  10. UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, ...

    Benzinga

  11. Teva's Stock Falls After 2013 Guidance Falls Short

    Investors Business Daily

  12. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE

    Benzinga

  13. Your Kid's Acne Medicine Seem Pricy? It Is, and Here's Why -- And ...

    YCharts

  14. UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Mylan

    Benzinga

  15. 52-Week High Companies: MYL, CBE, CCI, CM

    GuruFocus

  16. Stocks Get Small Boost With Weak Volume

    Investors Business Daily

  17. Stocks Turn Modestly Higher; HDFC Clears Flat Base

    Investors Business Daily

  18. Mylan OK'd for Pfizer generic

    Investors Business Daily

  19. DaVita, Mylan Lead Med Stocks Clustered In IBD 50

    Investors Business Daily

  20. Stocks Hitting 52-Week Highs

    Benzinga

  21. Mylan To Wall Street: Forget Patent Cliff, We'll Grow

    Investors Business Daily

  22. Mylan Inc (MYL) COO Harry Korman sells 119,059 Shares

    GuruFocus

  23. Weekly Top Insider Sells: MSFT, GOOG, FB, MYL, and NEE

    GuruFocus

  24. Generics Giant Mylan Sees Growth Return In Europe

    Investors Business Daily

  25. IBD 50 Outperforms Peer Indexes; Landscape Is Tough

    Investors Business Daily

  26. Stocks Hitting 52-Week Highs

    Benzinga

  27. Mylan Inc (MYL) Executive Chairman Robert J Coury sells 675,000 Shares

    GuruFocus

  28. Benzinga's Top Upgrades

    Benzinga

  29. Mylan Laboratories Inc. Reports Operating Results (10-Q)

    GuruFocus

  30. Mylan Announces Settlement Agreement for its First-to-File Generic ...

    Benzinga

  31. Mylan Launches Generic Avapro Tablets and Generic Avalide Tablets

    Benzinga

  32. Delays for India's Ranbaxy Good News for Novartis and its $5.7 ...

    YCharts

  33. Mylan Launches Generic Version of Antivert Tablets

    Benzinga

  34. Generic Drugs: Watson Up, Impax Awaits FDA Decision

    Investors Business Daily

  35. Pfizer

    Investors Business Daily

  36. Pfizer, Mylan Agree On Generic Detrol LA Launch

    Investors Business Daily

  37. 52-Week High Companies: HD, MMC, MMM, MYL, PFE

    GuruFocus

  38. Why Is John Paulson Doing So Badly?

    GuruFocus

  39. Watson Stock Hits High On Generic Lidoderm Approval

    Investors Business Daily

  40. Pfizer and Mylan Partner for Generics Business in Japan

    Benzinga

  41. Mylan Launches Lithium Carbonate Extended-Release Tablets USP

    Benzinga

  42. Four Ways to Make More and Lose Less

    GuruFocus

  43. Mylan Specialty and Pfizer Announce Licensing Agreement for ...

    Benzinga

  44. Mylan Specialty and Pfizer Announce Licensing Agreement for EpiPen ...

    Benzinga

  45. Mylan Launches Generic Version of Singulair Tablets and Singulair ...

    Benzinga

  46. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ...

    Benzinga

  47. Mylan Signs Agreement with Gilead to Accelerate Access to Generic ...

    Benzinga

  48. Mylan Launches Generic Version of Sporanox® Capsules

    Benzinga

  49. Mylan Laboratories Inc. Reports Operating Results (10-Q)

    GuruFocus

  50. Benzinga's Microcap Movers for Wednesday July 18, 2012

    Benzinga

  51. Somaxon Pharmaceuticals Announces Settlement of Silenor Patent ...

    Benzinga

  52. Mylan Announces Settlement Agreement in Litigation Relating to its ...

    Benzinga

  53. Consumer Prices Rose More than Expected in June

    Benzinga

  54. Producer Prices Unexpectedly Rose in June

    Benzinga

  55. Mylan Launches Generic Version of Lithobid Tablets

    Benzinga

  56. Mylan Confirms First-to-File Patent Challenge Relating to Pristiq ...

    Benzinga

  57. Teva Jumps, But Still Must Repair Its Chart Further

    Investors Business Daily

  58. Teva Beats Momenta, Mylan in Copaxone Case

    Benzinga

  59. Teva Stock Rises After Patent Victory On Key Drug

    Investors Business Daily

  60. Stocks Open In The Red: Teva Pharmaceuticals Surges

    Investors Business Daily

  61. Mylan Comments on Copaxone Ruling; 2012 Earnings Guidance and 2013 ...

    Benzinga

  62. Mylan Laboratories (MYL) Sees 2x Normal Put Volume with Stock Up 0.3%

    At Market Intelligence Center

  63. Headline CPI Falls as Inflation Remains In Check

    Benzinga

  64. Producer Prices Drop More than Expected in May

    Benzinga

  65. Teva, Mylan settle dispute

    Investors Business Daily

  66. Mylan To Launch Competing Generic Version Of Provigil

    Investors Business Daily

  67. UPDATE: Bank of America Raises PO on Mylan to $27

    Benzinga

  68. Mylan Settles Provigil(R) Litigation With Teva

    Benzinga

  69. Mylan Canada Receives Health Canada Approval for Generic Version ...

    Benzinga

  70. Mylan Launches Generic Version of Lipitor

    Benzinga

  71. Mylan Announces Settlement Agreement in Patent Infringement ...

    Benzinga

  72. Mylan Launches Generic Version of Bonviva Film Coated Tablets in ...

    Benzinga

  73. Mylan Launches Generic Version of Viramune Tablets

    Benzinga

  74. Mylan Launches Generic Version of Plavix Tablets

    Benzinga

  75. Mylan Increases 2012 Guidance Range to $2.45-2.55 vs $2.30-2.50; ...

    Benzinga

  76. Mylan Laboratories (MYL) Falls 0.5% with Overall Market, Sees 11x ...

    At Market Intelligence Center

  77. Mylan Continues to Pursue Damages and Injunction Against ...

    at Benzinga

  78. Mylan Launches First Equivalent Product to Lexapro Tablets

    at Benzinga

  79. Shire Diversifies Drugs To Offset Generic Threat

    at IBD

  80. Teva Is Driving Forward

    at GuruFocus

  81. A Peek Into The Market Before The Trading Starts

    at Benzinga

  82. Mylan tops, sees profit rising

    at IBD

  83. Mylan Laboratories Inc. Reports Operating Results (10-K)

    at GuruFocus

  84. Earnings Roundup

    at Benzinga

  85. Mylan Resolves Defamation Litigation Against Pittsburgh ...

    at Benzinga

  86. Major Indexes Lower, Zynga Soars Ahead Of Earnings

    at IBD

  87. Stocks Down In Afternoon, But Rackspace Hits New High

    at IBD

  88. Stocks Lower At Midday On Weak Retail Sales Report

    at IBD

  89. Stocks Slump At Open; Rackspace Hosting Pegs New High

    at IBD

  90. Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ...

    at Benzinga

  91. Weekly Top Insider Sells: MNST, APOL, VRSK, MYL

    at GuruFocus

  92. Mylan Laboratories Inc. (MYL) Executive Chairman Robert J Coury ...

    at GuruFocus

  93. Mylan Confirms First-to-File Patent Challenge Relating to Actoplus ...

    at Benzinga

  94. ETF Showdown: Fun With Pharma

    at Benzinga

  95. End-of-Day Market Summary for December 27 2011

    at Benzinga

  96. Mylan Launches First Generic Version of Teveten Tablets

    at Benzinga

  97. A Peek Into The Market Before The Trading Starts

    at Benzinga

  98. Mylan Receives Approval for First-to-File Generic Keppra XR ...

    at Benzinga

  99. Notable Put Options Activity in Mylan

    at Benzinga

  100. Mylan Launches Generic Version of Toprol-XL Tablets

    at Benzinga
People viewing MYL also viewed: , , , , , ,
Marketplace
Trading Center